Breast Cancer Research: Charting Future Directions
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Cancer Biology and Oncology".
Deadline for manuscript submissions: 31 December 2025 | Viewed by 179
Special Issue Editor
Special Issue Information
Dear Colleagues,
Breast cancer remains one of the most prevalent and complex malignancies affecting people worldwide, especially women. As our understanding of its molecular, genetic, and environmental underpinnings deepens, so does the need to rethink diagnosis, treatment, survivorship, and prevention strategies.
This Special Issue titled “Breast Cancer Research: Charting Future Directions” brings together cutting-edge studies, innovative methodologies, and forward-looking perspectives that aim to shape the next chapter in breast cancer research. It will highlight key advancements in personalized medicine, biomarkers for early detection, immunotherapy, and patient-reported outcomes.
By fostering dialogue between clinicians and researchers, this Special Issue aims to not only reflect the current state of the field but also inspire new inquiries that will accelerate discovery and improve outcomes for all individuals affected by breast cancer. We hope it will serve as both a resource and a catalyst for researchers committed to advancing the science and management of breast cancer well into the future.
Dr. Mohamad Adam Bujang
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- personalized medicine
- biomarkers for early detection
- immunotherapy
- patient-reported outcomes
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
